INVENTIVA (EPA:IVA) | WebDisclosure

Basculer en Français

11119	Companies
244817	Keywords
172888	Articles
131997	Press releases

Home
Companies
INVENTIVA

PRESS RELEASE

published on 10/07/2025 at 22:00, 11 months 27 days ago

Inventiva présentera plusieurs abstracts lors du congrès AASLD The Liver Meeting® 2025
Inventiva présentera plusieurs abstracts au congrès AASLD The Liver Meeting® 2025. Présentation d'une comparaison histologie numérique sur lame biopsies NATiV3 et pathologie numérique de lanifibranor préclinique

Pathologie Numérique Inventiva Lanifibranor AASLD The Liver Meeting 2025 Histologie Numérique
PRESS RELEASE

published on 10/07/2025 at 22:00, 11 months 27 days ago

Inventiva to Present Multiple Abstracts at AASLD The Liver Meeting® 2025
Inventiva to present multiple abstracts at AASLD The Liver Meeting® 2025 showcasing digital pathology data and therapeutic benefits of lanifibranor in MASH treatment. Visit booth #745 for more

Digital Pathology Inventiva MASH Lanifibranor AASLD The Liver Meeting
BRIEF

published on 10/01/2025 at 08:35, 1 year ago

Andrew Obenshain nommé PDG d'Inventiva

Transition De Leadership Développement De Médicaments Inventiva Traitement MASH André Obenshain
BRIEF

published on 10/01/2025 at 08:35, 1 year ago

Andrew Obenshain Appointed as CEO of Inventiva

Leadership Transition Drug Development Inventiva MASH Treatment Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 1 year ago

Inventiva annonce la nomination d’Andrew Obenshain au poste de Directeur Général
Inventiva annonce la nomination d'Andrew Obenshain au poste de Directeur Général, marquant une transition de leadership stratégique pour la société biopharmaceutique spécialisée dans le traitement de la MASH

Directeur Général Transition De Leadership Inventiva MASH Andrew Obenshain
PRESS RELEASE

published on 10/01/2025 at 08:30, 1 year ago

Inventiva Appoints Andrew Obenshain as Chief Executive Officer
Inventiva appoints Andrew Obenshain as Chief Executive Officer, succeeding Frédéric Cren, to lead company's growth and prepare for potential commercialization in the United States

Chief Executive Officer Inventiva MASH Frédéric Cren Andrew Obenshain
PRESS RELEASE

published on 09/29/2025 at 13:55, 1 year ago

RFS
BRIEF

published on 09/24/2025 at 22:05, 1 year ago

Inventiva organise un événement pour analystes et investisseurs

Phase 3 Événement Inventiva MASH Lanifibranor
BRIEF

published on 09/24/2025 at 22:05, 1 year ago

Inventiva organizes an event for analysts and investors

Event Phase 3 Inventiva MASH Lanifibranor
PRESS RELEASE

published on 09/24/2025 at 22:00, 1 year ago

Inventiva organise un événement analystes et investisseurs le 8 octobre 2025
Inventiva organisera un événement pour analystes et investisseurs le 8 octobre 2025 à New York, présentant lanifibranor, traitement de la stéatohépatite (MASH)

Événement Inventiva MASH Analystes Lanifibranor

Accesswire

Published on 10/03/2026 at 02:35, 1 day 12 hours ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 20 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 2 days ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 1 hour ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 1 hour ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/04/2026 at 06:05, 8 hours 35 minutes ago

Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 9 hours 25 minutes ago

SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 22 hours 55 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 14 hours ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 18 hours ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding

Les Echos

Published on 10/02/2026 at 17:45, 1 day 20 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 20 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 21 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 21 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 1 day 21 hours ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE